First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software

ConditionAortic Valve Stenosis

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age65+

SponsorCaranx Medical

About this trial

The trial aims to evaluate the feasibility and safety of Caranx Medical TAVIPILOT augmented reality guidance software during Transcatheter Aortic Valve Replacement Procedures.

Eligibility criteria

Qualifiers

Patients aged ≥65

Indicated for transfemoral TAVR for severe aortic stenosis

Disqualifiers

None

Trial design

Treatments tested in this trial

TAVR using a guidance software

Treatment groups

10 Participants

are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Caranx Medical

Lead sponsor

Source ClinicalTrials.gov